ARID3C
gene geneOn this page
Summary
ARID3C (AT-rich interaction domain 3C, HGNC:21209) is a protein-coding gene on chromosome 9p13.3, encoding AT-rich interactive domain-containing protein 3C (A6NKF2). Transcription factor involved in monocyte-to-macrophage differentiation.
This gene is a member of the ARID (AT-rich interaction domain) family of proteins. The ARID domain is a helix-turn-helix motif-based DNA-binding domain. ARID family members have roles in embryonic patterning, cell lineage gene regulation, cell cycle control, transcriptional regulation and possibly in chromatin structure modification.
Source: NCBI Gene 138715 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 73 total
- MANE Select transcript:
NM_001017363
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:21209 |
| Approved symbol | ARID3C |
| Name | AT-rich interaction domain 3C |
| Location | 9p13.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000205143 |
| Ensembl biotype | protein_coding |
| OMIM | 620868 |
| Entrez | 138715 |
Gene structure
Transcript identifiers
Ensembl transcripts: 3 — 3 protein_coding
ENST00000378909, ENST00000692051, ENST00000876981
RefSeq mRNA: 2 — MANE Select: NM_001017363
NM_001017363, NM_001371945
CCDS: CCDS35006
Canonical transcript exons
ENST00000378909 — 8 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001479230 | 34621049 | 34621558 |
| ENSE00001479231 | 34622020 | 34622109 |
| ENSE00001479232 | 34622347 | 34622529 |
| ENSE00001479233 | 34623425 | 34623714 |
| ENSE00001479234 | 34623864 | 34624047 |
| ENSE00001479236 | 34627697 | 34628086 |
| ENSE00001770344 | 34625742 | 34625814 |
| ENSE00003966710 | 34628917 | 34629066 |
Expression profiles
Bgee: expression breadth broad, 62 present calls, max score 85.77.
Top tissues by expression
102 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 85.77 | gold quality |
| right lobe of liver | UBERON:0001114 | 79.76 | gold quality |
| liver | UBERON:0002107 | 75.09 | gold quality |
| ventricular zone | UBERON:0003053 | 72.06 | gold quality |
| ganglionic eminence | UBERON:0004023 | 70.32 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 59.10 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 58.79 | gold quality |
| cerebellum | UBERON:0002037 | 58.64 | gold quality |
| cerebellar cortex | UBERON:0002129 | 58.60 | gold quality |
| stromal cell of endometrium | CL:0002255 | 57.12 | gold quality |
| tibial nerve | UBERON:0001323 | 56.96 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 55.20 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 54.28 | gold quality |
| primary visual cortex | UBERON:0002436 | 54.10 | gold quality |
| right frontal lobe | UBERON:0002810 | 53.92 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 53.64 | gold quality |
| frontal cortex | UBERON:0001870 | 52.78 | gold quality |
| prefrontal cortex | UBERON:0000451 | 51.89 | gold quality |
| cerebral cortex | UBERON:0000956 | 51.32 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 51.25 | gold quality |
| hypothalamus | UBERON:0001898 | 51.17 | gold quality |
| sural nerve | UBERON:0015488 | 50.87 | gold quality |
| nucleus accumbens | UBERON:0001882 | 49.72 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 49.61 | gold quality |
| brain | UBERON:0000955 | 49.31 | gold quality |
| skin of abdomen | UBERON:0001416 | 48.94 | gold quality |
| zone of skin | UBERON:0000014 | 48.42 | gold quality |
| skin of leg | UBERON:0001511 | 48.16 | gold quality |
| caudate nucleus | UBERON:0001873 | 44.74 | gold quality |
| amygdala | UBERON:0001876 | 44.71 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 1.14 |
Regulation
Is transcription factor: no
Upstream regulators (CollecTRI, top): NR1I2
Literature-anchored findings (GeneRIF, showing 1)
- this report introduces Brightlike as an additional functional member of the family of ARID proteins, which should be considered in regulatory circuits, previously ascribed to be mediated by Bright.[ARID3C] (PMID:21955986)
Cross-species orthologs
5 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | arid3c | ENSDARG00000067729 |
| mus_musculus | Arid3c | ENSMUSG00000066224 |
| rattus_norvegicus | Arid3c | ENSRNOG00000013416 |
| drosophila_melanogaster | retn | FBGN0004795 |
| caenorhabditis_elegans | cfi-1 | WBGENE00000476 |
Paralogs (2): ARID3A (ENSG00000116017), ARID3B (ENSG00000179361)
Protein
Protein identifiers
AT-rich interactive domain-containing protein 3C — A6NKF2 (reviewed: A6NKF2)
All UniProt accessions (2): A6NKF2, A0A8I5QL24
UniProt curated annotations — full annotation on UniProt →
Function. Transcription factor involved in monocyte-to-macrophage differentiation. Forms a complex with NPM1 to translocate to the nucleus, acting as a transcription factor that promotes the expression of the genes involved in macrophage differentiation, such as STAT3, STAT1 and JUNB.
Subunit / interactions. Interacts (via REKLES DOMAIN) with NPM1; the interaction mediates ARID3C nuclear shuttling.
Subcellular location. Nucleus.
Domain organisation. REKLES domain is required for interaction with NPM1 and nuclear shuttling.
RefSeq proteins (2): NP_001017363, NP_001358874 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001606 | ARID_dom | Domain |
| IPR023334 | REKLES_domain | Domain |
| IPR036431 | ARID_dom_sf | Homologous_superfamily |
| IPR045147 | ARI3A/B/C | Family |
Pfam: PF01388
UniProt features (13 total): compositionally biased region 4, region of interest 3, domain 2, sequence variant 2, chain 1, mutagenesis site 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-A6NKF2-F1 | 67.29 | 0.34 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Mutagenesis-validated functional residues (1):
| Position | Phenotype |
|---|---|
| 381–385 | strongly decreases interaction with npm1. located in cytoplasm and nucleus. reduced binding to target genes promoters. |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 24 (showing top):
GOBP_MYELOID_CELL_DIFFERENTIATION, BENPORATH_ES_WITH_H3K27ME3, GOBP_MYELOID_LEUKOCYTE_DIFFERENTIATION, chr9p13, GOBP_MACROPHAGE_DIFFERENTIATION, GOMF_CHROMATIN_BINDING, MEISSNER_NPC_HCP_WITH_H3K4ME2_AND_H3K27ME3, MEISSNER_BRAIN_HCP_WITH_H3K4ME2_AND_H3K27ME3, MARTENS_TRETINOIN_RESPONSE_UP, GOBP_POSITIVE_REGULATION_OF_TRANSCRIPTION_BY_RNA_POLYMERASE_II, GOBP_MONONUCLEAR_CELL_DIFFERENTIATION, GOMF_TRANSCRIPTION_REGULATOR_ACTIVITY, ZNF184_TARGET_GENES, ZNF407_TARGET_GENES, GOCC_MEMBRANE_MICRODOMAIN
GO Biological Process (3): regulation of transcription by RNA polymerase II (GO:0006357), macrophage differentiation (GO:0030225), positive regulation of transcription by RNA polymerase II (GO:0045944)
GO Molecular Function (4): DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), DNA binding (GO:0003677), chromatin binding (GO:0003682), protein binding (GO:0005515)
GO Cellular Component (3): nucleus (GO:0005634), cytoplasm (GO:0005737), membrane raft (GO:0045121)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| transcription by RNA polymerase II | 2 |
| regulation of transcription by RNA polymerase II | 2 |
| binding | 2 |
| regulation of DNA-templated transcription | 1 |
| myeloid leukocyte differentiation | 1 |
| mononuclear cell differentiation | 1 |
| positive regulation of DNA-templated transcription | 1 |
| chromatin | 1 |
| RNA polymerase II transcription regulatory region sequence-specific DNA binding | 1 |
| DNA-binding transcription factor activity | 1 |
| nucleic acid binding | 1 |
| intracellular membrane-bounded organelle | 1 |
| intracellular anatomical structure | 1 |
| cellular anatomical structure | 1 |
| membrane microdomain | 1 |
Protein interactions and networks
STRING
674 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ARID3C | CROCC2 | H7BZ55 | 453 |
| ARID3C | BRK1 | Q8WUW1 | 449 |
| ARID3C | FAM219A | Q8IW50 | 448 |
| ARID3C | SPATA31F1 | Q6ZU69 | 433 |
| ARID3C | PTPRR | Q15256 | 393 |
| ARID3C | JARID2 | Q92833 | 393 |
| ARID3C | AGAP4 | Q96P64 | 393 |
| ARID3C | RPP25L | Q8N5L8 | 370 |
| ARID3C | A0A087WTP8 | A0A087WTP8 | 337 |
| ARID3C | CHCHD1 | Q96BP2 | 325 |
| ARID3C | CPNE2 | Q96FN4 | 320 |
| ARID3C | MYORG | Q6NSJ0 | 315 |
| ARID3C | SPMIP6 | Q8NCR6 | 313 |
| ARID3C | LINGO3 | P0C6S8 | 311 |
| ARID3C | TMEM147 | Q9BVK8 | 310 |
| ARID3C | ARID5A | Q03989 | 310 |
IntAct
15 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| ARID3C | C14orf119 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ARID3C | CBX4 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ARID3C | RNF4 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ARID3A | ARID3C | psi-mi:“MI:0914”(association) | 0.530 |
| OR2T1 | ARID3C | psi-mi:“MI:0915”(physical association) | 0.400 |
| SPRR2E | ARID3C | psi-mi:“MI:0915”(physical association) | 0.400 |
| ARID3C | ZNF609 | psi-mi:“MI:0914”(association) | 0.350 |
| C14orf119 | ARID3C | psi-mi:“MI:0915”(physical association) | 0.000 |
| ARID3C | CBX4 | psi-mi:“MI:0915”(physical association) | 0.000 |
| ARID3C | RNF4 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (10): ARID3C (Affinity Capture-MS), ARID3C (Two-hybrid), ARID3C (Two-hybrid), ARID3C (Two-hybrid), ARID3C (Affinity Capture-MS), ARID3C (Affinity Capture-MS), ARID3B (Affinity Capture-MS), C17orf70 (Affinity Capture-MS), ZNF609 (Affinity Capture-MS), ARID3C (Affinity Capture-MS)
ESM2 similar proteins: A2A5E6, A5PK23, A6NKF2, A6PWV5, B0K011, E9Q6W4, O02786, O95402, P09086, P13297, P55198, Q00196, Q08DS3, Q0VDQ9, Q29013, Q2NKI2, Q2VL80, Q2VL82, Q2VL83, Q2VL85, Q2VL86, Q569K4, Q5XI28, Q62255, Q66K41, Q6AXX3, Q6PBT9, Q86V15, Q8BXJ8, Q8IVH2, Q8K4J6, Q8TAX0, Q8VD12, Q8VDL9, Q8WUU4, Q92766, Q969V6, Q96PM9, Q9BXA9, Q9BZE0
Diamond homologs: A2BEA6, A2BH40, A2CG63, A6NKF2, A6PWV5, E1BLP6, E2R9X2, E7F888, E9Q4N7, F8VPQ2, O02326, O14497, O74365, P29374, P29375, P41229, P41230, Q03214, Q03989, Q14865, Q24573, Q30DN6, Q38JA7, Q3SWY1, Q3U108, Q3UXZ9, Q4H3P5, Q4LE39, Q5F3R2, Q5XGD9, Q5XUN4, Q5ZJ69, Q62431, Q6GQD7, Q6IQX0, Q8BM75, Q8IN94, Q8IVW6, Q8MQH7, Q8NFD5
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
73 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 72 |
| Likely benign | 1 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
859 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 9:34623713:ACCTA:A | acceptor_loss | 1.0000 |
| 9:34623714:CCTAG:C | acceptor_loss | 1.0000 |
| 9:34623716:T:G | acceptor_loss | 1.0000 |
| 9:34623837:C:A | donor_gain | 1.0000 |
| 9:34623852:C:A | donor_gain | 1.0000 |
| 9:34623862:A:AC | donor_gain | 1.0000 |
| 9:34623863:C:CA | donor_gain | 1.0000 |
| 9:34623927:T:TA | donor_gain | 1.0000 |
| 9:34623928:C:A | donor_gain | 1.0000 |
| 9:34624043:CGTCC:C | acceptor_gain | 1.0000 |
| 9:34624045:TCCC:T | acceptor_loss | 1.0000 |
| 9:34624048:C:CC | acceptor_gain | 1.0000 |
| 9:34627691:TCCTA:T | donor_loss | 1.0000 |
| 9:34627692:CCTAC:C | donor_loss | 1.0000 |
| 9:34627693:CTA:C | donor_loss | 1.0000 |
| 9:34627694:TAC:T | donor_loss | 1.0000 |
| 9:34627696:CCTG:C | donor_gain | 1.0000 |
| 9:34623449:G:C | donor_gain | 0.9900 |
| 9:34623710:TGTAC:T | acceptor_gain | 0.9900 |
| 9:34623715:C:CC | acceptor_gain | 0.9900 |
| 9:34623859:CTCA:C | donor_loss | 0.9900 |
| 9:34623861:CACT:C | donor_loss | 0.9900 |
| 9:34623863:CTG:C | donor_gain | 0.9900 |
| 9:34623873:A:AC | donor_gain | 0.9900 |
| 9:34623874:G:C | donor_gain | 0.9900 |
| 9:34623954:T:TA | donor_gain | 0.9900 |
| 9:34623954:TCC:T | donor_gain | 0.9900 |
| 9:34624045:TCC:T | acceptor_gain | 0.9900 |
| 9:34624046:CC:C | acceptor_gain | 0.9900 |
| 9:34624046:CCC:C | acceptor_gain | 0.9900 |
AlphaMissense
2635 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 9:34623713:A:G | Y193H | 1.000 |
| 9:34623873:A:G | L189P | 1.000 |
| 9:34623878:G:C | F187L | 1.000 |
| 9:34623878:G:T | F187L | 1.000 |
| 9:34623879:A:C | F187C | 1.000 |
| 9:34623880:A:G | F187L | 1.000 |
| 9:34623932:C:A | W169C | 1.000 |
| 9:34623932:C:G | W169C | 1.000 |
| 9:34623934:A:G | W169R | 1.000 |
| 9:34623934:A:T | W169R | 1.000 |
| 9:34623939:T:A | K167I | 1.000 |
| 9:34625776:A:C | F119L | 1.000 |
| 9:34625776:A:T | F119L | 1.000 |
| 9:34625778:A:G | F119L | 1.000 |
| 9:34623643:G:T | A216D | 0.999 |
| 9:34623652:A:G | L213P | 0.999 |
| 9:34623666:G:C | S208R | 0.999 |
| 9:34623666:G:T | S208R | 0.999 |
| 9:34623668:T:G | S208R | 0.999 |
| 9:34623692:A:C | Y200D | 0.999 |
| 9:34623698:A:C | Y198D | 0.999 |
| 9:34623700:A:G | L197P | 0.999 |
| 9:34623700:A:T | L197Q | 0.999 |
| 9:34623707:T:C | K195E | 0.999 |
| 9:34623712:T:C | Y193C | 0.999 |
| 9:34623871:G:T | R190S | 0.999 |
| 9:34623873:A:T | L189Q | 0.999 |
| 9:34623879:A:G | F187S | 0.999 |
| 9:34623880:A:T | F187I | 0.999 |
| 9:34623882:G:T | A186D | 0.999 |
dbSNP variants (sampled 300 via entrez): RS1000222849 (9:34634014 AACT>A), RS1000284556 (9:34623572 G>A,C,T), RS1000447387 (9:34628472 GAGGCAGAGGTATC>G), RS1000729035 (9:34634301 C>A), RS1000867464 (9:34624492 C>T), RS1000872532 (9:34623409 C>A,T), RS1000969902 (9:34630558 C>T), RS1001126819 (9:34624761 C>T), RS1001154189 (9:34629214 G>A,C), RS1001197437 (9:34623004 G>A), RS1001220249 (9:34627460 C>A), RS1001389991 (9:34633665 A>G), RS1001705187 (9:34629221 G>A), RS1002051103 (9:34623033 C>A,T), RS1002225885 (9:34628795 G>T)
Disease associations
OMIM: gene MIM:620868 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
11 total (human), top 11 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Arsenic | affects methylation, increases methylation | 2 |
| Benzo(a)pyrene | increases methylation, increases mutagenesis | 2 |
| ethyl-p-hydroxybenzoate | decreases expression | 1 |
| benzo(e)pyrene | increases methylation | 1 |
| S-(1,2-dichlorovinyl)cysteine | affects response to substance, increases expression, affects cotreatment | 1 |
| bisphenol S | increases methylation | 1 |
| Lipopolysaccharides | affects response to substance, increases expression, affects cotreatment | 1 |
| Methapyrilene | increases methylation | 1 |
| Valproic Acid | increases methylation | 1 |
| Cyclosporine | decreases methylation | 1 |
| Okadaic Acid | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.